Ledger.Open graph →
SEC Form D · filed September 23, 2024

Synaptogenix, Inc

Offering
$3.2M
Sold
$3.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Joshua J. Silverman · New York, NYDirectorDaniel L. Alkon · New York, NYExec · DirectorWilliam J. Singer · New York, NYDirectorBruce T. Bernstein · New York, NYDirectorAlan J. Tuchman · New York, NYExec · DirectorRobert J. Weinstein · New York, NYExecJonathan L. Schechter · New York, NYDirectorBruce T. Bernstein · New York, NYDirectorAlan J. Tuchman · New York, NYExec · DirectorJoshua J. Silverman · New York, NYDirectorRobert J. Weinstein · New York, NYExecDaniel L. Alkon · New York, NYExec · DirectorJonathan L. Schechter · New York, NYDirectorWilliam J. Singer · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗